On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance
暂无分享,去创建一个
[1] L. Mandarino,et al. Decreased Activation of Skeletal Muscle Glycogen Synthase by Mixed-Meal Ingestion in NIDDM , 1988, Diabetes.
[2] L. Rossetti,et al. Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.
[3] R. DeFronzo,et al. Glucose Toxicity , 1990, Diabetes Care.
[4] E. Kraegen,et al. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. , 1997, Metabolism: clinical and experimental.
[5] C Cobelli,et al. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. , 1996, Diabetes.
[6] Y. Kruszynska,et al. Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects. , 1998, Diabetes.
[7] Z Trajanoski,et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.
[8] L. DiPietro,et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.
[9] G. Dohm,et al. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. , 1988, The Journal of clinical investigation.
[10] Simon C Watkins,et al. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. , 1996, The Journal of clinical investigation.
[11] Richard Wise,et al. Science, medicine, and the future , 1998 .
[12] E. Kraegen,et al. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. , 1998, Metabolism: clinical and experimental.
[13] E. Newsholme,et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.
[14] S. Lillioja,et al. Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action , 1997, Diabetes.
[15] K. Petersen,et al. 13C/31P NMR studies on the mechanism of insulin resistance in obesity. , 1998, Diabetes.
[16] J. McGarry,et al. What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.
[17] A. Saltiel,et al. Signaling pathways in insulin action: molecular targets of insulin resistance. , 2000, The Journal of clinical investigation.
[18] G. Reaven,et al. Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? , 1976, The American journal of medicine.
[19] R. Shulman,et al. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Krolewski,et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.
[21] R. DeFronzo. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.
[22] Yii-Der I. Chen,et al. Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.
[23] R. Bergman,et al. Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. , 1990, Metabolism: clinical and experimental.
[24] R. Bergman,et al. Insulin transport across capillaries is rate limiting for insulin action in dogs. , 1989, The Journal of clinical investigation.
[25] K. Petersen,et al. Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.
[26] G. Shulman,et al. Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.
[27] R. DeFronzo. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.
[28] E. Kraegen,et al. A New Antidiabetic Agent, BRL 49653, Reduces Lipid Availability and Improves Insulin Action and Glucoregulation in the Rat , 1994, Diabetes.
[29] P. Scifo,et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. , 1999, Diabetes.
[30] D L Rothman,et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.
[31] B V Howard,et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.
[32] E. Kraegen,et al. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. , 1997, Diabetes.
[33] R. Shulman,et al. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.
[34] P. J. Randle,et al. THE GLUCOSE FATTY ACID CYCLE IN OBESITY AND MATURITY ONSET DIABETES MELLITUS , 1965, Annals of the New York Academy of Sciences.
[35] K. Frayn. Insulin resistance and lipid metabolism , 1993 .
[36] S. Lillioja,et al. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. , 1984, The Journal of clinical investigation.
[37] G. Shulman,et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.
[38] P. J. Randle,et al. Regulation of Glucose Uptake by Muscle , 1962 .
[39] R G Shulman,et al. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.
[40] B. Howard. Insulin resistance and lipid metabolism. , 1999, The American journal of cardiology.
[41] E. Kraegen,et al. Alterations in the Expression and Cellular Localization of Protein Kinase C Isozymes ε and θ Are Associated With Insulin Resistance in Skeletal Muscle of the High-Fat–Fed Rat , 1997, Diabetes.
[42] S. O’Rahilly,et al. Science, medicine, and the future Non-insulin dependent diabetes mellitus: the gathering storm , 1997, BMJ.
[43] Claudio Cobelli,et al. Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM , 1996, Diabetes.
[44] J. Colca,et al. Reduced Expression of Hexokinase II in Insulin-Resistant Diabetes , 1995, Diabetes.
[45] G. Shulman,et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. , 1999, Diabetes.
[46] E. Newsholme,et al. Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. , 1964, The Biochemical journal.
[47] B. Kahn. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. , 1992, The Journal of clinical investigation.
[48] G. Shulman,et al. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. , 1997, Diabetes.